Ultrasound/Magnetic Targeting with SPIO-DOX-Microbubble Complex for Image-Guided Drug Delivery in Brain Tumors

One of the greatest challenges in the deployment of chemotherapeutic drugs against brain tumors is ensuring that sufficient drug concentrations reach the tumor, while minimizing drug accumulation at undesired sites. Recently, injection of therapeutic agents following blood-brain barrier (BBB) opening by focused ultrasound (FUS) with microbubbles (MBs) has been shown to enhance drug delivery in targeted brain regions. Nevertheless, the distribution and quantitative deposition of agents delivered to the brain are still hard to estimate. Based on our previous work on superparamagnetic iron oxide (SPIO)-loaded MBs, we present a novel theranostic complex of SPIO-Doxorubicin (DOX)-conjugated MB (SD-MB) for drug delivery to the brain. Magnetic labeling of the drug enables direct visualization via magnetic resonance imaging, and also facilitates magnetic targeting (MT) to actively enhance targeted deposition of the drug. In a rat glioma model, we demonstrated that FUS sonication can be used with SD-MBs to simultaneously facilitate BBB opening and allow dual ultrasound/magnetic targeting of chemotherapeutic agent (DOX) delivery. The accumulation of SD complex within brain tumors can be significantly enhanced by MT (25.7 fold of DOX, 7.6 fold of SPIO). The change in relaxation rate R2 (1/T2) within tumors was highly correlated with SD deposition as quantified by high performance liquid chromatography (R2 = 0.93) and inductively coupled plasma-atomic emission spectroscopy (R2 = 0.94), demonstrating real-time monitoring of DOX distribution. Our results suggest that SD-MBs can serve as multifunction agents to achieve advanced molecular theranostics.

[1]  Hua Guo,et al.  Microbubbles as a novel contrast agent for brain MRI , 2009, NeuroImage.

[2]  Cristina Carvalho,et al.  Doxorubicin: the good, the bad and the ugly effect. , 2009, Current medicinal chemistry.

[3]  A. Olivi,et al.  Intratumoral chemotherapy. , 1995, Neurosurgery.

[4]  S. Torp,et al.  Nanoparticle delivery to the brain--By focused ultrasound and self-assembled nanoparticle-stabilized microbubbles. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[5]  N. Gu,et al.  Multiple emulsion microbubbles for ultrasound imaging , 2008 .

[6]  K. Hynynen,et al.  Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. , 2001, Radiology.

[7]  M. V. van Zandvoort,et al.  Theranostic USPIO‐Loaded Microbubbles for Mediating and Monitoring Blood‐Brain Barrier Permeation , 2015, Advanced functional materials.

[8]  Ning Gu,et al.  Microbubbles with surface coated by superparamagnetic iron oxide nanoparticles , 2012 .

[9]  C. McArdle,et al.  Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug. , 1986, British Journal of Cancer.

[10]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[11]  Po-Chun Chu,et al.  Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles: Usefulness for distinguishing between focused ultrasound‐induced blood–brain barrier disruption and brain hemorrhage , 2009, Journal of magnetic resonance imaging : JMRI.

[12]  Chih-Kuang Yeh,et al.  Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. , 2012, Biomaterials.

[13]  Natalia Vykhodtseva,et al.  Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Abhalaxmi Singh,et al.  Magnetic nanoparticles: a novel platform for cancer theranostics. , 2014, Drug discovery today.

[15]  D. Carvajal,et al.  Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. , 1994, International immunology.

[16]  Mu-Yi Hua,et al.  Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain , 2010, Proceedings of the National Academy of Sciences.

[17]  Shailendra Verma,et al.  Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclines. , 2008, Cancer treatment reviews.

[18]  Satya V. V. N. Kothapalli,et al.  Magnetite nanoparticles can be coupled to microbubbles to support multimodal imaging. , 2012, Biomacromolecules.

[19]  Ajit Raisinghani,et al.  Physical principles of microbubble ultrasound contrast agents. , 2002, The American journal of cardiology.

[20]  Jia Jian,et al.  Targeted Antiangiogenesis Gene Therapy Using Targeted Cationic Microbubbles Conjugated with CD105 Antibody Compared with Untargeted Cationic and Neutral Microbubbles , 2015, Theranostics.

[21]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[22]  Magnetic properties of nanosized transition metal colloids: the influence of noble metal coating , 1999 .

[23]  K. Widder,et al.  Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. , 1979, Advances in pharmacology and chemotherapy.

[24]  K. Hoang-Xuan,et al.  Primary brain tumours in adults , 2003, The Lancet.

[25]  M. Pajic,et al.  Moderate increase in Mdr1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancer. , 2009, Cancer research.

[26]  Patrick Couvreur,et al.  Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. , 2012, Chemical reviews.

[27]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[28]  E Stride,et al.  The influence of surface adsorption on microbubble dynamics , 2008, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[29]  T. Yen,et al.  Contrast-Enhanced Ultrasound Imaging for the Detection of Focused Ultrasound-Induced Blood-Brain Barrier Opening , 2014, Theranostics.

[30]  Natalia Vykhodtseva,et al.  The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[31]  S. Grossman,et al.  Current management of glioblastoma multiforme. , 2004, Seminars in oncology.

[32]  T. Yen,et al.  SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery. , 2013, Biomaterials.

[33]  Mu-Yi Hua,et al.  Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. , 2010, Radiology.

[34]  Yu-Ting Weng,et al.  Paramagnetic perfluorocarbon-filled albumin-(Gd-DTPA) microbubbles for the induction of focused-ultrasound-induced blood–brain barrier opening and concurrent MR and ultrasound imaging , 2012, Physics in medicine and biology.

[35]  K. Hoang-Xuan,et al.  Primary brain tumours in adults , 2003, The Lancet.

[36]  Yu Zhang,et al.  Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. , 2009, Biomaterials.

[37]  M. Versluis,et al.  Sonoprinting and the importance of microbubble loading for the ultrasound mediated cellular delivery of nanoparticles. , 2016, Biomaterials.

[38]  B. Werner,et al.  Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[39]  Elizabeth Nance,et al.  Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[40]  M. Boss,et al.  Magnetic resonance properties of Gd(III)-bound lipid-coated microbubbles and their cavitation fragments. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[41]  Shaoqin Gong,et al.  Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging. , 2010, Biomaterials.

[42]  N. McDannold,et al.  Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study. , 2015, Journal of controlled release : official journal of the Controlled Release Society.